Drug intelligence / Profile preview

(2S)-2-amino-4-(3-aminopropanoylamino)butanoic acid

Development stage: Unknown
Modality: Small Molecules

Overview

(2S)-2-amino-4-(3-aminopropanoylamino)butanoic acid is a synthetic dipeptide, chemically characterized as an amino acid derivative. It is classified as a pharmaceutical compound. While its precise biological activity and therapeutic indications are not detailed in available public databases, its chemical structure suggests potential as a small molecule with possible interactions in biological systems, similar to other dipeptides like carnosine or homocarnosine, though it is a distinct entity.

Other names: (2s)-4-(Beta-Alanylamino)-2-Aminobutanoic Acid

Beyond the preview

Go deeper on (2S)-2-amino-4-(3-aminopropanoylamino)butanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (2S)-2-amino-4-(3-aminopropanoylamino)butanoic acid.

Explore the full profile